Evidence map›Paper›PMID 23190896›Full record

ArticleThe Journal of investigative dermatology2013

Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens.

Adam J Friedman, Jenny Phan, David O Schairer, Jackson Champer, Min Qin, Aslan Pirouz, Karin Blecher-Paz, Ami Oren, Phil T Liu, Robert L Modlin and 1 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of investigative dermatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 329 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Biomacromolecules · 2025
    Article
  11. Antibiotic-ResistantMicroorganisms · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Adam J FriedmanDivision of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
Jenny Phan
David O Schairer
Jackson Champer
Min Qin
Aslan Pirouz
Karin Blecher-Paz
Ami Oren
Phil T Liu
Robert L Modlin
Jenny Kim
University of California, Los Angeles · USAlbert Einstein College of Medicine · USWest Los Angeles College · US

Funding

GRANULYSIN: ANTIMICROBIAL/ANTI-INFLAMMATORY ROLE IN ACNER01AI059091 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODLIN, ROBERT L · 2005 to 2009
$1.8M
Innate Immunity in Acne VulgarisR01AR053542 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KIM, JENNY J · 2009 to 2013
$1.3M
Innate and Adaptive Immunity in Acne VulgarisK08AR048551 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KIM, JENNY J · 2002 to 2006
$544k
NIAID NIH HHS R01 AI059091NIAMS NIH HHS K08 AR048551NIAMS NIH HHS K08 AR48551NIAMS NIH HHS R01 AR053542
6 · The paper itself

Abstract

Advances in nanotechnology have demonstrated potential application of nanoparticles (NPs) for effective and targeted drug delivery. Here we investigated the antimicrobial and immunological properties and the feasibility of using NPs to deliver antimicrobial agents to treat a cutaneous pathogen. NPs synthesized with chitosan and alginate demonstrated a direct antimicrobial activity in vitro against Propionibacterium acnes, the bacterium linked to the pathogenesis of acne. By electron microscopy (EM) imaging, chitosan-alginate NPs were found to induce the disruption of the P. acnes cell membrane, providing a mechanism for the bactericidal effect. The chitosan-alginate NPs also exhibited anti-inflammatory properties as they inhibited P. acnes-induced inflammatory cytokine production in human monocytes and keratinocytes. Furthermore, benzoyl peroxide (BP), a commonly used antiacne drug, was effectively encapsulated in the chitosan-alginate NPs and demonstrated superior antimicrobial activity against P. acnes compared with BP alone while demonstrating less toxicity to eukaryotic cells. Together, these data suggest the potential utility of topical delivery of chitosan-alginate NP-encapsulated drug therapy for the treatment of dermatologic conditions with infectious and inflammatory components.

Indexed as

Acne VulgarisAdministration, TopicalAlginatesAnti-Infective AgentsAnti-Inflammatory AgentsBenzoyl PeroxideCell LineCells, CulturedChitosanCytokinesDrug Delivery SystemsFeasibility StudiesGlucuronic AcidHexuronic AcidsHumansKeratinocytesAlginatesAnti-Infective AgentsAnti-Inflammatory AgentsBenzoyl PeroxideChitosanCytokinesGlucuronic AcidHexuronic Acids

Identifiers

PMID23190896
PMCPMC3631294
OpenAlexW2020522743

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.